Page last updated: 2024-08-24

naxagolide and bp 897

naxagolide has been researched along with bp 897 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Guillin, O; Hwang, DR; Hwang, Y; Laruelle, M; Narendran, R; Rabiner, E; Reeder, S; Scher, E; Slifstein, M	1

Other Studies

1 other study(ies) available for naxagolide and bp 897

Article	Year
Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo. Synapse (New York, N.Y.), 2006, Dec-01, Volume: 60, Issue:7 Topics: Animals; Binding, Competitive; Brain; Brain Mapping; Carbon Radioisotopes; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Down-Regulation; Female; Globus Pallidus; Male; Oxazines; Papio anubis; Piperazines; Positron-Emission Tomography; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D3; Species Specificity; Time Factors	2006

Article

Year

Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.

Synapse (New York, N.Y.), 2006, Dec-01, Volume: 60, Issue:7

Topics: Animals; Binding, Competitive; Brain; Brain Mapping; Carbon Radioisotopes; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Down-Regulation; Female; Globus Pallidus; Male; Oxazines; Papio anubis; Piperazines; Positron-Emission Tomography; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D3; Species Specificity; Time Factors

2006